Trusted Press Release Distribution   Plans | Login    

Briefing Search


Author Details
Suite 9884 27 Upper Pembroke Street, Dublin 2

Bookmark and Share
Dual Therapy Stent Market Analysis with Ongoing Trends and Growth Forecast 2017-2027
The market in North America is anticipated to hold the largest share of dual therapy stent in the global market, followed by Western Europe, owing to the high prevalence and incidence of coronary artery disease., 8/10/2018 - Dual therapy stent market is primarily driven by elevating a number of geriatric population on the global level as they are at high risk of developing arterial disorders. In addition, increasing prevalence and incidence of atherosclerosis pertaining to unhealthy lifestyle and obesity are also driving the growth of the dual therapy stent market. For instance, according to the research conducted, more than 15.8 million individual is suffering from coronary artery disease, and approximately 8 million of them have has heart attack. However, factors such as reduction in the drug-eluting stents pricing, and availability of alternative therapy procedure are the major obstacle to the market growth of dual therapy stent. Increasing preference for drugs over the surgical procedure of stent implants and increased risk of developing late-stage thrombosis are limiting the growth of dual therapy stent market.

Request TOC of this Report@

Dual Therapy Stent Market: Segmentation

The global dual therapy stent market can be segmented on the basis of usage type, end-user, and region.

On the basis of usage type, global dual therapy stent market can be segmented as:

Single Use

Multi Use

On the basis of end user, global dual therapy stent market can be segmented as:


Specialty Clinics

Ambulatory Surgical Centers

On the basis of region, global Dual Therapy Stent market can be segmented as:

North America

Latin America

Western Europe

Eastern Europe

Asia Pacific Excluding Japan


Middle East and Africa 

Dual Therapy Stent Market: Overview

Dual therapy stent is a modification of previous developed drug-eluting stent which offers enhanced drug delivery and stent flexibility. The key alteration of dual therapy stent includes the combination of drug-eluting stents which addition coating of anti-CD34 antibodies. This results in delivering safety, longer usability, and improved drug efficacy. Since the introduction of dual therapy stents, various technological advancement has been witnessed to generate a product offering accurate delivery of drug and safety concerns.

To know more about the Dual Therapy Stent Market, Visit the link @

FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2013 Proserve Technology, Inc.